Pregnenolone reorganizes cytoskeleton to promote neuron development via CLIP1
Viktoryia KolasiD, Yi-Ting Wu, Jose Sandino A. BandoniliD, Bon‐chu ChungiD
Abstract
Pregnenolone (P5) is a neurosteroid produced in the brain. It improves cognitive function and protects against cannabis intoxication as well as spinal cord injury. P5 activates CLIP1, which helps microtubule polymerization at its growing end; however, the significance of P5 activation of CLIP1 in the brain is still unknown. Here we examined the roles of P5 in cultured neurons and in zebrafish cerebellum. We show that P5 promotes neurite outgrowth and facilitates axon development of cultured cerebellar granule neurons. P5 also changes the morphology of axon growth cone and promotes dynamic microtubule invasion into the distal part of filopodia at the growth cone. We have used CRISPR to disrupt clip1a in zebrafish, disrupting the ability of P5 to change microtubule dynamics and growth cone morphology, as well as to reorganize cytoskeleton. In vivo, P5 accelerated cerebellum development in WT but not clip1a mutant zebrafish, and expression of exogenous CLIP1 in clip1a mutant promoted cerebellum development in response to P5. Thus, we have delineated the pathway by which P5 promotes cerebellum development by activating CLIP1 to promote microtubule dynamics leading to increased microtubule penetration into the growth cone and accelerated neurite outgrowth. This study reveals the mechanism by which P5 and CLIP1 function to promote neural development. Significance Statement1. We have elucidated the mechanism of pregnenolone (P5) actionP5 enhances brain functions, but its mode of action was unclear. Here we show that P5 activates CLIP1 to promote microtubule dynamics at the growth cone and to accelerate neural development. 2. We have generated a zebrafish model of CLIP1 deficiencyCLIP1 deficiency causes intellectual disability and defective neural development. Our zebrafish model can be used to study mechanisms related to this disease and other microtubule defects. 3. We point to therapeutic intervention of neurological diseases using P5P5 is beneficial to the brain. We elucidate the mechanism of P5 action, thus accelerate the development of therapeutics using P5 and its derivatives.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Astrocyte-derived PTPRZ1 regulates astrocyte morphology and excitatory synaptogenesis
Alex R. Eaker, Hayli E Spence-Osorio, Katherine T. Baldwin·bioRxiv·Apr 30, 2025
- Abnormal morphology and synaptogenic signaling in astrocytes following prenatal opioid exposure
Ethan B. Niebergall, Daron Weekley, … William Christopher Risher·CellsPeer-reviewed·May 14, 2024
- p75NTR prevents the onset of cerebellar granule cell migration via RhoA activation
Juan Pablo Zanin, Wilma Friedman·eLifePeer-reviewed·Aug 8, 2022
- 'Mitotic' kinesin-5 is a dynamic brake for axonal growth
Wen Lü, Brad S. Lee, … Vladimir I. Gelfand·DevelopmentPeer-reviewed·Apr 14, 2025
- p75 neurotrophin receptor in pre-adolescent prefrontal PV interneurons promotes cognitive flexibility in adult mice
Pegah Chehrazi, Karen Ka Yan Lee, … Graziella Di Cristo·Biological PsychiatryPeer-reviewed·Apr 27, 2023
- Clemastine induces an impairment in developmental myelination
Ana Palma, Juan Carlos Chara, … Marı́a Domercq·Frontiers in Cell and Developmental BiologyPeer-reviewed·Mar 17, 2022